Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Ischemic Heart Disease

Free Subscription Articles published in Circulation Retrieve available abstracts of 232 articles: HTML format Text format

Single Articles

July 2018
1. FUERNAU G, Beck J, Desch S, Eitel I, et al
   Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction - The Randomized SHOCK-COOL Trial.
   Circulation. 2018 Jul 19. pii: CIRCULATIONAHA.117.032722.
   PubMed     Text format     Abstract available
   
   
   
2. MCCORD J, Newby LK, deFilippi CR
   Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Infarction.
   Circulation. 2018;138:316-318.
   PubMed     Text format    
   
   
   
3. GOLDBERG IJ, Reue K, Abumrad NA, Bickel PE, et al
   Deciphering the Role of Lipid Droplets in Cardiovascular Disease: A Report From the 2017 National Heart, Lung, and Blood Institute Workshop.
   Circulation. 2018;138:305-315.
   PubMed     Text format     Abstract available
   
   
   
4. SHEN YM, Nagalla S
   Hypercoagulable Workup in Thrombotic Cardiovascular Diseases.
   Circulation. 2018;138:229-231.
   PubMed     Text format    
   
   
   
5. BONACA MP, Sabatine MS
   Response by Bonaca and Sabatine to Letters Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Resea
   Circulation. 2018;138:222-223.
   PubMed     Text format    
   
   
   
6. ALKHALIL M
   Letter by Alkhalil Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibitio
   Circulation. 2018;138:220-221.
   PubMed     Text format    
   
   
   
7. CALABRO P, Gragnano F, Cesaro A
   Letter by Calabro et al Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhi
   Circulation. 2018;138:218-219.
   PubMed     Text format    
   
   
   
8. IBRAHIM K, Shah R, McEvoy JW
   Response by Ibrahim et al to Letter Regarding Article, "Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggreg
   Circulation. 2018;138:216-217.
   PubMed     Text format    
   
   
   
9. KIKKERT WJ, Delewi R, Claessen BEPM
   Letter by Kikkert et al Regarding Article, "Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggregation With T
   Circulation. 2018;138:214-215.
   PubMed     Text format    
   
   
   
10. BEALE AL, Meyer P, Marwick TH, Lam CSP, et al
    Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction.
    Circulation. 2018;138:198-205.
    PubMed     Text format     Abstract available
    
    
    
11. KOENIG W
    Low-Grade Inflammation Modifies Cardiovascular Risk Even at Very Low LDL-C Levels: Are We Aiming for a Dual Target Concept?
    Circulation. 2018;138:150-153.
    PubMed     Text format    
    
    
    
12. BASCOM KE, Seder DB
    Response by Bascom and Seder to Letter Regarding Article, "Derivation and Validation of the CREST Model for Very Early Prediction of Circulatory Etiology Death in Patients Without ST-Segment-Elevation Myocardial Infarction After Cardiac Arrest".
    Circulation. 2018;138:120-121.
    PubMed     Text format    
    
    
    
13. VOICU S, Megarbane B, Sideris G
    Letter by Voicu et al Regarding Article, "Derivation and Validation of the CREST Model for Very Early Prediction of Circulatory Etiology Death in Patients Without ST-Segment-Elevation Myocardial Infarction After Cardiac Arrest".
    Circulation. 2018;138:118-119.
    PubMed     Text format    
    
    
    
14. ZARZOUR A, Kim HW, Weintraub NL
    Understanding Obesity-Related Cardiovascular Disease: It's All About Balance.
    Circulation. 2018;138:64-66.
    PubMed     Text format    
    
    
    
15. NASSIF ME, Kosiborod M
    Are We Ready to Bell The Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes.
    Circulation. 2018;138:4-6.
    PubMed     Text format    
    
    
    
16. SHIRAKAWA K, Endo J, Kataoka M, Katsumata Y, et al
    IL-10-STAT3-Galectin-3 Axis is Essential for Osteopontin-Producing Reparative Macrophage Polarization After Myocardial Infarction.
    Circulation. 2018 Jul 2. pii: CIRCULATIONAHA.118.035047.
    PubMed     Text format     Abstract available
    
    
    
17. SHAH ASV, Stelzle D, Lee KK, Beck EJ, et al
    Global Burden of Atherosclerotic Cardiovascular Disease in People Living with the Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis.
    Circulation. 2018 Jul 2. pii: CIRCULATIONAHA.117.033369.
    PubMed     Text format     Abstract available
    
    
    June 2018
18. LABARTHE DR, Lloyd-Jones DM
    50x50x50: Cardiovascular Health and the Cardiovascular Disease Endgame.
    Circulation. 2018 Jun 27. pii: CIRCULATIONAHA.118.035985.
    PubMed     Text format     Abstract available
    
    
    
19. BANGALORE S, Toklu B, Patel N, Feit F, et al
    Newer Generation Ultra-Thin Strut Drug-Eluting Stents versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: A Meta-Analysis of Randomized Trials.
    Circulation. 2018 Jun 26. pii: CIRCULATIONAHA.118.034456.
    PubMed     Text format     Abstract available
    
    
    
20. NEUEN BL, Ohkuma T, Neal B, Matthews DR, et al
    Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function: Data from the CANVAS Program.
    Circulation. 2018 Jun 25. pii: CIRCULATIONAHA.118.035901.
    PubMed     Text format     Abstract available
    
    
    
21. RICCIOTTI E, Castro C, Tang SY, Briggs WTE, et al
    Cyclooxygenase-2, Asymmetric Dimethylarginine and the Cardiovascular Hazard from NSAIDs.
    Circulation. 2018 Jun 21. pii: CIRCULATIONAHA.118.033540.
    PubMed     Text format     Abstract available
    
    
    
22. ORME RC, Parker WAE, Thomas MR, Judge HM, et al
    Study of Two Dose Regimens of Ticagrelor Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease (STEEL-PCI).
    Circulation. 2018 Jun 21. pii: CIRCULATIONAHA.118.034790.
    PubMed     Text format     Abstract available
    
    
    
23. THIENE G, Saffitz JE
    Autopsy as a Source of Discovery in Cardiovascular Medicine: Then and Now.
    Circulation. 2018;137:2683-2685.
    PubMed     Text format    
    
    
    
24. ZHANG M, Solomon DH, Desai RJ, Kang EH, et al
    Assessment of Cardiovascular Risk in Older Patients with Gout Initiating Febuxostat versus Allopurinol: A Population-Based Cohort Study.
    Circulation. 2018 Jun 13. pii: CIRCULATIONAHA.118.033992.
    PubMed     Text format     Abstract available
    
    
    
25. BOHULA EA, Wiviott SD, Giugliano RP, Park JG, et al
    Response by Bohula et al to Letters Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
    Circulation. 2018;137:2662-2663.
    PubMed     Text format    
    
    
    
26. KOH KK
    Letter by Koh Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2660-2661.
    PubMed     Text format    
    
    
    
27. CORDERO A, Bertomeu-Gonzalez V, Rodriguez-Manero M
    Letter by Cordero et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2658-2659.
    PubMed     Text format    
    
    
    
28. THOMOPOULOS C, Michalopoulou H
    Letter by Thomopoulos and Michalopoulou Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Tr
    Circulation. 2018;137:2656-2657.
    PubMed     Text format    
    
    
    
29. DEL PINTO R, Ferri C, Borghi C
    Letter by Del Pinto et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2654-2655.
    PubMed     Text format    
    
    
    
30. GARCIA-GARCIA HM, McFadden EP, Farb A, Mehran R, et al
    Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.
    Circulation. 2018;137:2635-2650.
    PubMed     Text format     Abstract available
    
    
    
31. ROBERTS R
    Genetic Risk Stratification: Tipping Point for Global Primary Prevention of Coronary Artery Disease.
    Circulation. 2018;137:2554-2556.
    PubMed     Text format    
    
    
    
32. UDDIN SMI, Mirbolouk M, Dardari Z, Feldman DI, et al
    Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.
    Circulation. 2018 Jun 11. pii: CIRCULATIONAHA.118.033990.
    PubMed     Text format     Abstract available
    
    
    
33. BADERTSCHER P, Boeddinghaus J, Twerenbold R, Nestelberger T, et al
    Direct Comparison of the 0/1h and 0/3h Algorithms for Early Rule-Out of Acute Myocardial Infarction.
    Circulation. 2018;137:2536-2538.
    PubMed     Text format    
    
    
    
34. PFEFFER MA, Rutherford JD
    Therapeutic Attenuation of Cardiac Remodeling After Acute Myocardial Infarction: A Conversation With Marc A. Pfeffer, MD, PhD.
    Circulation. 2018;137:2430-2434.
    PubMed     Text format    
    
    
    
35. HYMAN MC, Patel PA, Giri J
    Response by Hyman et al to Letter Regarding Article, "Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights From the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Car
    Circulation. 2018;137:2545-2546.
    PubMed     Text format    
    
    
    
36. SNIECINSKI RM, Mackensen GB, Kertai MD
    Letter by Sniecinski et al Regarding Article, "Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology
    Circulation. 2018;137:2543-2544.
    PubMed     Text format    
    
    
    
37. MAGNANI JW, Mujahid MS, Aronow HD, Cene CW, et al
    Health Literacy and Cardiovascular Disease: Fundamental Relevance to Primary and Secondary Prevention: A Scientific Statement From the American Heart Association.
    Circulation. 2018 Jun 4. pii: CIR.0000000000000579.
    PubMed     Text format     Abstract available
    
    
    May 2018
38. DEVEREAUX PJ
    Suboptimal Outcome of Myocardial Infarction After Noncardiac Surgery: Physicians Can and Should Do More.
    Circulation. 2018;137:2340-2343.
    PubMed     Text format    
    
    
    
39. 
    Correction to: Angiography Versus Hemodynamics to Predict the Natural History of Coronary Stenoses: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation 2 Substudy.
    Circulation. 2018;137:e820.
    PubMed     Text format    
    
    
    
40. VALLEJO-VAZ AJ, Packard CJ, Ray KK
    Response by Vallejo-Vaz et al to Letters Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL
    Circulation. 2018;137:2419-2420.
    PubMed     Text format    
    
    
    
41. KOH KK
    Letter by Koh Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From th
    Circulation. 2018;137:2417-2418.
    PubMed     Text format    
    
    
    
42. LOWE AL, Collet TH, Rodondi N
    Letter by Lowe et al Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses
    Circulation. 2018;137:2415-2416.
    PubMed     Text format    
    
    
    
43. RIJNBERG FM, Hazekamp MG, Wentzel JJ, de Koning PJH, et al
    Energetics of Blood Flow in Cardiovascular Disease: Concept and Clinical Implications of Adverse Energetics in Patients With a Fontan Circulation.
    Circulation. 2018;137:2393-2407.
    PubMed     Text format     Abstract available
    
    
    
44. VOLGMAN AS, Palaniappan LS, Aggarwal NT, Gupta M, et al
    Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association.
    Circulation. 2018 May 24. pii: CIR.0000000000000580.
    PubMed     Text format     Abstract available
    
    
    
45. KIRTANE AJ
    ORBITA2: Bringing Some Oxygen Back to PCI in Stable Ischemic Heart Disease?
    Circulation. 2018 May 22. pii: CIRCULATIONAHA.118.035331.
    PubMed     Text format     Abstract available
    
    
    
46. PUYMIRAT E, Simon T, Danchin N
    Response by Puymirat et al to Letter Regarding Article, "Acute Myocardial Infarction Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST Elevation or Non-ST
    Circulation. 2018;137:2307-2308.
    PubMed     Text format    
    
    
    
47. RODRIGUEZ-GRANILLO GA, Rodriguez AE, Milei J
    Letter by Rodriguez-Granillo et al Regarding Article, "Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-
    Circulation. 2018;137:2305-2306.
    PubMed     Text format    
    
    
    
48. AL-LAMEE R, Howard JP, Shun-Shin MJ, Thompson D, et al
    Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease: Physiology-Stratified Analysis of ORBITA.
    Circulation. 2018 May 22. pii: CIRCULATIONAHA.118.033801.
    PubMed     Text format     Abstract available
    
    
    
49. OLDGREN J, Sundstrom J
    Response by Oldgren and Sundstrom to Letter Regarding Article, "Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort Study".
    Circulation. 2018;137:2313.
    PubMed     Text format    
    
    
    
50. YI-TONG W
    Letter by Yi-tong Regarding Article, "Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort Study".
    Circulation. 2018;137:2312.
    PubMed     Text format    
    
    
    
51. MENDY A
    Association of Urinary Nitrate With Lower Prevalence of Hypertension and Stroke and With Reduced Risk of Cardiovascular Mortality.
    Circulation. 2018;137:2295-2297.
    PubMed     Text format    
    
    
    
52. KENGNE AP, Ntsekhe M
    Challenges of Cardiovascular Disease Risk Evaluation in People Living With HIV Infection.
    Circulation. 2018;137:2215-2217.
    PubMed     Text format    
    
    
    
53. LINGVAY I, Leiter LA
    Use of GLP-1 RAs in Cardiovascular Disease Prevention: A Practical Guide.
    Circulation. 2018;137:2200-2202.
    PubMed     Text format    
    
    
    
54. RIMM EB, Appel LJ, Chiuve SE, Djousse L, et al
    Seafood Long-Chain n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: A Science Advisory From the American Heart Association.
    Circulation. 2018 May 17. pii: CIR.0000000000000574.
    PubMed     Text format     Abstract available
    
    
    
55. HENG EL, Diller GP, Gatzoulis MA, Babu-Narayan SV, et al
    Response by Heng et al to Letter Regarding Article, "Immediate and Midterm Cardiac Remodeling After Surgical Pulmonary Valve Replacement in Adults With Repaired Tetralogy of Fallot: A Prospective Cardiovascular Magnetic Resonance and Clinical Study".
    Circulation. 2018;137:2186-2187.
    PubMed     Text format    
    
    
    
56. ROMEO JLR, Bogers AJJC, Mokhles MM
    Letter by Romeo et al Regarding Article, "Immediate and Midterm Cardiac Remodeling After Surgical Pulmonary Valve Replacement in Adults With Repaired Tetralogy of Fallot: A Prospective Cardiovascular Magnetic Resonance and Clinical Study".
    Circulation. 2018;137:2184-2185.
    PubMed     Text format    
    
    
    
57. VERMA S, Bhatt DL, Bain SC, Buse JB, et al
    Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER Trial.
    Circulation. 2018;137:2179-2183.
    PubMed     Text format    
    
    
    
58. SCHULTZ WM, Kelli HM, Lisko JC, Varghese T, et al
    Socioeconomic Status and Cardiovascular Outcomes: Challenges and Interventions.
    Circulation. 2018;137:2166-2178.
    PubMed     Text format     Abstract available
    
    
    
59. BROWN HL, Warner JJ, Gianos E, Gulati M, et al
    Promoting Risk Identification and Reduction of Cardiovascular Disease in Women Through Collaboration With Obstetricians and Gynecologists: A Presidential Advisory From the American Heart Association and the American College of Obstetricians and Gyneco
    Circulation. 2018 May 10. pii: CIR.0000000000000582.
    PubMed     Text format    
    
    
    
60. MAGNUSSEN C, Ojeda FM, Schnabel RB
    Response by Magnussen et al to Letter Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk
    Circulation. 2018;137:2087-2088.
    PubMed     Text format    
    
    
    
61. WANG Y
    Letter by Wang Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)"
    Circulation. 2018;137:2085-2086.
    PubMed     Text format    
    
    
    
62. EL-BATTRAWY I, Borggrefe M, Akin I
    Letter by El-Battrawy et al Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessmen
    Circulation. 2018;137:2083-2084.
    PubMed     Text format    
    
    
    
63. BARTER PJ
    High- Versus Low-Dose Statin: Effects on Cardiovascular Events and All-Cause Death.
    Circulation. 2018;137:2013-2015.
    PubMed     Text format    
    
    
    
64. TAGUCHI I, Iimuro S, Iwata H, Takashima H, et al
    High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.
    Circulation. 2018;137:1997-2009.
    PubMed     Text format     Abstract available
    
    
    
65. MAYNE SL, Widome R, Carroll AJ, Schreiner PJ, et al
    Longitudinal Associations of Smoke-Free Policies and Incident Cardiovascular Disease: CARDIA Study.
    Circulation. 2018 May 7. pii: CIRCULATIONAHA.117.032302.
    PubMed     Text format     Abstract available
    
    
    
66. KARAM N, Pechmajou L, Dumas F, Bougouin W, et al
    Comprehensive Assessment of Coronary Artery Disease in Sports-Related Sudden Cardiac Arrest.
    Circulation. 2018 May 2. pii: CIRCULATIONAHA.118.034664.
    PubMed     Text format     Abstract available
    
    
    
67. GOLDWASSER D, Elizari M, Bayes de Luna A
    Response by Goldwasser et al to Letter Regarding Article, "Chronic Myocardial Infarction: Where Is It Located?"
    Circulation. 2018;137:1977-1978.
    PubMed     Text format    
    
    
    
68. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Chronic Myocardial Infarction: Where Is It Located?"
    Circulation. 2018;137:1976.
    PubMed     Text format    
    
    
    
69. BULLUCK H, Dharmakumar R, Arai AE, Berry C, et al
    Cardiovascular Magnetic Resonance in Acute ST-Segment-Elevation Myocardial Infarction: Recent Advances, Controversies, and Future Directions.
    Circulation. 2018;137:1949-1964.
    PubMed     Text format     Abstract available
    
    
    
70. THOMPSON PD
    Fitness, Exercise, and Coronary Calcification.
    Circulation. 2018;137:1896-1898.
    PubMed     Text format    
    
    
    April 2018
71. WEI WQ, Li X, Feng Q, Kubo M, et al
    LPA Variants are Associated with Residual Cardiovascular Risk in Patients Receiving Statins.
    Circulation. 2018 Apr 27. pii: CIRCULATIONAHA.117.031356.
    PubMed     Text format     Abstract available
    
    
    
72. KLEINMAN ME, Perkins GD, Bhanji F, Billi JE, et al
    ILCOR Scientific Knowledge Gaps and Clinical Research Priorities for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: A Consensus Statement.
    Circulation. 2018 Apr 26. pii: CIR.0000000000000561.
    PubMed     Text format     Abstract available
    
    
    
73. VAN DER LINDEN N, Wildi K, Twerenbold R, Pickering JW, et al
    Combining High Sensitivity Cardiac Troponin I and Cardiac Troponin T in the Early Diagnosis of Acute Myocardial Infarction.
    Circulation. 2018 Apr 24. pii: CIRCULATIONAHA.117.032003.
    PubMed     Text format     Abstract available
    
    
    
74. RUBINI GIMENEZ M, Badertscher P, Twerenbold R, Boeddinghaus J, et al
    Impact of the US Food and Drug Administration-Approved Sex-Specific Cutoff Values for High-Sensitivity Cardiac Troponin T to Diagnose Myocardial Infarction.
    Circulation. 2018;137:1867-1869.
    PubMed     Text format    
    
    
    
75. HASEEB S, Alexander B, Baranchuk A
    Response by Haseeb et al to Letter Regarding Article, "Wine and Cardiovascular Health: A Comprehensive Review".
    Circulation. 2018;137:1880-1881.
    PubMed     Text format    
    
    
    
76. THORNTON SN
    Letter by Thornton Regarding Article, "Wine and Cardiovascular Health: A Comprehensive Review".
    Circulation. 2018;137:1879.
    PubMed     Text format    
    
    
    
77. HUANG ZP, Wang DZ
    miR-22 in Smooth Muscle Cells: A Potential Therapy for Cardiovascular Disease.
    Circulation. 2018;137:1842-1845.
    PubMed     Text format    
    
    
    
78. FERNANDEZ-JIMENEZ R, Martin-Garcia A, Barreiro-Perez M, Sanchez-Gonzalez J, et al
    Response by Fernandez-Jimenez et al to Letters Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage".
    Circulation. 2018;137:1754-1755.
    PubMed     Text format    
    
    
    
79. STIERMAIER T, Bogaert J, Eitel I
    Letter by Stiermaier et al Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage".
    Circulation. 2018;137:1752-1753.
    PubMed     Text format    
    
    
    
80. SACHA J, Feusette P
    Letter by Sacha and Feusette Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage".
    Circulation. 2018;137:1750-1751.
    PubMed     Text format    
    
    
    
81. BULLUCK H, Hausenloy DJ
    Letter by Bulluck and Hausenloy Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage".
    Circulation. 2018;137:1748-1749.
    PubMed     Text format    
    
    
    
82. VERHEUGT FWA
    Return of Oral Anticoagulation in Chronic Stable Coronary Disease.
    Circulation. 2018;137:1655-1657.
    PubMed     Text format    
    
    
    
83. REDFORS B, Chen S, Crowley A, Ben-Yehuda O, et al
    B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis from the EXCEL Trial.
    Circulation. 2018 Apr 17. pii: CIRCULATIONAHA.118.033631.
    PubMed     Text format     Abstract available
    
    
    
84. AHMAD FS, Chan C, Rosenman MB, Post WS, et al
    Response by Ahmad et al to Letter Regarding Article, "Validity of Cardiovascular Data From Electronic Sources: The Multi-Ethnic Study of Atherosclerosis and HealthLNK".
    Circulation. 2018;137:1761-1762.
    PubMed     Text format    
    
    
    
85. MEWTON N, Bergerot C, Cornu C
    Letter by Mewton et al Regarding Article, "Validity of Cardiovascular Data From Electronic Sources: The Multi-Ethnic Study of Atherosclerosis and HealthLNK".
    Circulation. 2018;137:1759-1760.
    PubMed     Text format    
    
    
    
86. PACK QR, Priya A, Lagu TC, Pekow PS, et al
    Inpatient Echocardiography Use for Common Cardiovascular Conditions.
    Circulation. 2018;137:1745-1747.
    PubMed     Text format    
    
    
    
87. BAIBHAV B, Gedela M, Moulton M, Pavlides G, et al
    Role of Invasive Functional Assessment in Surgical Revascularization of Coronary Artery Disease.
    Circulation. 2018;137:1731-1739.
    PubMed     Text format     Abstract available
    
    
    
88. BAKAEEN FG, Svensson LG
    Why Don't We Kill 2 Birds with 1 Stone? Less Adverse Cardiac Events and Improved Survival With Multiarterial Coronary Artery Bypass Grafting.
    Circulation. 2018;137:1708-1711.
    PubMed     Text format    
    
    
    
89. GAUDINO M, Fremes SE, Taggart DP
    Continuing Conundrum of Multiple Arterial Conduits for Coronary Artery Bypass Grafting.
    Circulation. 2018;137:1658-1660.
    PubMed     Text format    
    
    
    
90. PATEL KV, Pandey A, de Lemos JA
    A Conceptual Framework for Addressing Residual Atherosclerotic Cardiovascular Disease Risk in the Era of Precision Medicine.
    Circulation. 2018 Apr 11. pii: CIRCULATIONAHA.118.035289.
    PubMed     Text format     Abstract available
    
    
    
91. FIOL-SALA M, Bayes de Luna A
    Response by Fiol-Sala and Bayes de Luna to Letter Regarding Article, "Acute Coronary Syndrome: What Is the Affected Artery? Where Is the Occlusion Located? And How Important Is the Myocardial Mass Involved?"
    Circulation. 2018;137:1653.
    PubMed     Text format    
    
    
    
92. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Acute Coronary Syndrome: What Is the Affected Artery? Where Is the Occlusion Located? And How Important Is the Myocardial Mass Involved?"
    Circulation. 2018;137:1652.
    PubMed     Text format    
    
    
    
93. NALLAMOTHU BK, Hill JA
    Response by Nallamothu and Hill to Letter Regarding Article, "Preprints and Cardiovascular Science: Prescient or Premature?"
    Circulation. 2018;137:1643-1644.
    PubMed     Text format    
    
    
    
94. KATRITSIS DG
    Letter by Katritsis Regarding Article, "Preprints and Cardiovascular Science: Prescient or Premature?"
    Circulation. 2018;137:1641-1642.
    PubMed     Text format    
    
    
    
95. SHARIFZADEHGAN A, Marijon E, Bougouin W, Karam N, et al
    Sudden Cardiovascular Arrest During Sexual Intercourse.
    Circulation. 2018;137:1638-1640.
    PubMed     Text format    
    
    
    
96. DUNBAR SB, Khavjou OA, Bakas T, Hunt G, et al
    Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association.
    Circulation. 2018 Apr 9. pii: CIR.0000000000000570.
    PubMed     Text format     Abstract available
    
    
    
97. TIKKANEN E, Gustafsson S, Ingelsson E
    Associations of Fitness, Physical Activity, Strength, and Genetic Risk With Cardiovascular Disease: Longitudinal Analyses in the UK Biobank Study.
    Circulation. 2018 Apr 9. pii: CIRCULATIONAHA.117.032432.
    PubMed     Text format     Abstract available
    
    
    
98. SABATINE MS, De Ferrari GM, Giugliano RP, Huber K, et al
    Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: An Analysis from FOURIER.
    Circulation. 2018 Apr 6. pii: CIRCULATIONAHA.118.034309.
    PubMed     Text format     Abstract available
    
    
    
99. VALLEJO-VAZ AJ, Fayyad R, Boekholdt SM, Hovingh GK, et al
    Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the Treating to New Targets (TNT) Trial.
    Circulation. 2018 Apr 4. pii: CIRCULATIONAHA.117.032318.
    PubMed     Text format     Abstract available
    
    
    
100. OLDE ENGBERINK RHG, van den Born BH, Peters-Sengers H, Vogt L, et al
     Response by Olde Engberink et al to Letter Regarding Article, "Use of a Single Baseline Versus Multiyear 24-Hour Urine Collection for Estimation of Long-Term Sodium Intake and Associated Cardiovascular and Renal Risk".
     Circulation. 2018;137:1538-1539.
     PubMed     Text format    
     
     
     
101. GRAUDAL N, Mente A
     Letter by Graudal and Mente Regarding Article, "Use of a Single Baseline Versus Multiyear 24-Hour Urine Collection for Estimation of Long-Term Sodium Intake and Associated Cardiovascular and Renal Risk".
     Circulation. 2018;137:1536-1537.
     PubMed     Text format    
     
     
     
102. AUGER N, Potter BJ, Bilodeau-Bertrand M, Paradis G, et al
     Long-Term Risk of Cardiovascular Disease in Women Who Have Had Infants With Heart Defects.
     Circulation. 2018 Apr 2. pii: CIRCULATIONAHA.117.030277.
     PubMed     Text format     Abstract available
     
     
     March 2018
103. PASUPATHY S, Tavella R, Beltrame JF
     Response by Pasupathy et al to Letters Regarding Article, "Early Use of N-acetylcysteine (NAC) With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Reduces Myocardial Inf
     Circulation. 2018;137:1424-1425.
     PubMed     Text format    
     
     
     
104. YE Z, Su Q, Li L
     Letter by Ye et al Regarding Article, "Early Use of N-Acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Tria
     Circulation. 2018;137:1422-1423.
     PubMed     Text format    
     
     
     
105. MANSOUR A, Le Breton H, Auffret V
     Letter by Mansour et al Regarding Article, "Early Use of N-Acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM
     Circulation. 2018;137:1420-1421.
     PubMed     Text format    
     
     
     
106. KHAN AA, Boyle AJ
     Letter by Khan and Boyle Regarding Article, "Early Use of N-Acetylcysteine (NAC) With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Reduces Myocardial Infarct Size (The
     Circulation. 2018;137:1418-1419.
     PubMed     Text format    
     
     
     
107. NEELAND IJ, Poirier P, Despres JP
     Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management.
     Circulation. 2018;137:1391-1406.
     PubMed     Text format     Abstract available
     
     
     
108. DELGADO V, Hundley WG
     Added Value of Cardiovascular Magnetic Resonance in Primary Mitral Regurgitation.
     Circulation. 2018;137:1361-1363.
     PubMed     Text format    
     
     
     
109. BRILAKIS ES
     Innovations in Radiation Safety During Cardiovascular Catheterization.
     Circulation. 2018;137:1317-1319.
     PubMed     Text format    
     
     
     
110. THIELE H, Desch S
     CULPRIT-SHOCK (Culprit Lesion Only PCI Versus Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock): Implications on Guideline Recommendations.
     Circulation. 2018;137:1314-1316.
     PubMed     Text format    
     
     
     
111. ZAUNER CA, Holshouser JW, Littmann L
     Ventricular Tachycardia and Electrocardiographic ST-Segment-Elevation Myocardial Infarction Without Coronary Artery Disease.
     Circulation. 2018;137:1287-1289.
     PubMed     Text format    
     
     
     
112. ANDERSSON C, Lyass A, Lin H, Kober L, et al
     Association of Genetic Variation in Coronary Artery Disease-Related Loci With the Risk of Heart Failure With Preserved Versus Reduced Ejection Fraction.
     Circulation. 2018;137:1290-1292.
     PubMed     Text format    
     
     
     
113. TURER CB, Brady TM, de Ferranti SD
     Obesity, Hypertension, and Dyslipidemia in Childhood Are Key Modifiable Antecedents of Adult Cardiovascular Disease: A Call to Action.
     Circulation. 2018;137:1256-1259.
     PubMed     Text format    
     
     
     
114. BETHEL MA, McMurray JJV
     Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist.
     Circulation. 2018;137:1218-1220.
     PubMed     Text format    
     
     
     
115. NADRUZ W JR, Claggett B, Henglin M, Shah AM, et al
     Widening Racial Differences in Risks for Coronary Heart Disease.
     Circulation. 2018;137:1195-1197.
     PubMed     Text format    
     
     
     
116. SCOTT JM, Nilsen TS, Gupta D, Jones LW, et al
     Exercise Therapy and Cardiovascular Toxicity in Cancer.
     Circulation. 2018;137:1176-1191.
     PubMed     Text format     Abstract available
     
     
     
117. CREA F, Liuzzo G
     Addressing Acute Coronary Syndromes: New Challenges and Opportunities After the CANTOS Trial (Canakinumab Anti-inflammatory Thrombosis Outcomes Study).
     Circulation. 2018;137:1100-1102.
     PubMed     Text format    
     
     
     
118. BOHULA EA, Giugliano RP, Leiter LA, Verma S, et al
     Inflammatory and Cholesterol Risk in the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Patients With Elevated Risk).
     Circulation. 2018 Mar 12. pii: CIRCULATIONAHA.118.034032.
     PubMed     Text format     Abstract available
     
     
     
119. FRANCHI F, Rollini F, Rivas Rios J, Rivas A, et al
     Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP (Switching Antiplatelet Therapy)-4 Study.
     Circulation. 2018 Mar 11. pii: CIRCULATIONAHA.118.033983.
     PubMed     Text format     Abstract available
     
     
     
120. RADHOLM K, Figtree G, Perkovic V, Solomon SD, et al
     Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).
     Circulation. 2018 Mar 11. pii: CIRCULATIONAHA.118.034222.
     PubMed     Text format     Abstract available
     
     
     
121. SMILOWITZ NR, Beckman JA, Sherman SE, Berger JS, et al
     Hospital Readmission After Perioperative Acute Myocardial Infarction Associated With Noncardiac Surgery.
     Circulation. 2018 Mar 10. pii: CIRCULATIONAHA.117.032086.
     PubMed     Text format     Abstract available
     
     
     
122. BLEWER AL, Abella BS
     Unmeasured Interface in Emergency Cardiovascular Care: How Do Dispatch-Assisted Telephone Cardiopulmonary Resuscitation and Bystander Training Interact?
     Circulation. 2018;137:996-998.
     PubMed     Text format    
     
     
     February 2018
123. KOSIBOROD M, Cavender MA, Fu AZ, Wilding JP, et al
     Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of C
     Circulation. 2018;137:989-991.
     PubMed     Text format    
     
     
     
124. JIN-SHAN H, Xue-Bin L
     Letter by Jin-shan and Xue-bin Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovas
     Circulation. 2018;137:988.
     PubMed     Text format    
     
     
     
125. TAEGTMEYER H, Karlstaedt A
     Letter by Taegtmeyer and Karlstaedt Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Card
     Circulation. 2018;137:986-987.
     PubMed     Text format    
     
     
     
126. KOH KK
     Letter by Koh Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in
     Circulation. 2018;137:984-985.
     PubMed     Text format    
     
     
     
127. TAMPAKI EC, Tampakis A, Pantos C
     Letter by Tampaki et al Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular O
     Circulation. 2018;137:982-983.
     PubMed     Text format    
     
     
     
128. KUEHN BM
     Gene-Editing Technology Accelerates Cardiovascular Research: Clinical Applications Being Explored.
     Circulation. 2018;137:973-974.
     PubMed     Text format    
     
     
     
129. HICKS KA, Mahaffey KW, Mehran R, Nissen SE, et al
     2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
     Circulation. 2018;137:961-972.
     PubMed     Text format     Abstract available
     
     
     
130. ANDERSON CAM
     Dietary Patterns to Reduce Weight and Optimize Cardiovascular Health: Persuasive Evidence for Promoting Multiple, Healthful Approaches.
     Circulation. 2018 Feb 26. pii: CIRCULATIONAHA.117.031429.
     PubMed     Text format     Abstract available
     
     
     
131. SOFI F, Dinu M, Pagliai G, Cesari F, et al
     Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet).
     Circulation. 2018 Feb 26. pii: CIRCULATIONAHA.117.030088.
     PubMed     Text format     Abstract available
     
     
     
132. HAYES SN, Kim ESH, Saw J, Adlam D, et al
     Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association.
     Circulation. 2018 Feb 22. pii: CIR.0000000000000564.
     PubMed     Text format     Abstract available
     
     
     
133. PAYNTER NP, Balasubramanian R, Giulianini F, Wang DD, et al
     Metabolic Predictors of Incident Coronary Heart Disease in Women.
     Circulation. 2018;137:841-853.
     PubMed     Text format     Abstract available
     
     
     
134. VACCARINO V, Sullivan S, Hammadah M, Wilmot K, et al
     Mental Stress-Induced-Myocardial Ischemia in Young Patients With Recent Myocardial Infarction: Sex Differences and Mechanisms.
     Circulation. 2018;137:794-805.
     PubMed     Text format     Abstract available
     
     
     
135. LICHTMAN JH, Leifheit EC, Safdar B, Bao H, et al
     Sex Differences in the Presentation and Perception of Symptoms Among Young Patients With Myocardial Infarction: Evidence from the VIRGO Study (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients).
     Circulation. 2018;137:781-790.
     PubMed     Text format     Abstract available
     
     
     
136. FRIEDMAN DJ, Parzynski CS, Heist EK, Russo AM, et al
     Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: A Report from the National Cardiovascular Data Registry.
     Circulation. 2018 Feb 20. pii: CIRCULATIONAHA.117.032167.
     PubMed     Text format     Abstract available
     
     
     
137. LERCHENMULLER C, Lerchenmueller MJ, Sorenson O
     Long-Term Analysis of Sex Differences in Prestigious Authorships in Cardiovascular Research Supported by the National Institutes of Health.
     Circulation. 2018;137:880-882.
     PubMed     Text format    
     
     
     
138. ZOET GA, Benschop L, Boersma E, Budde RPJ, et al
     Prevalence of Subclinical Coronary Artery Disease Assessed by Coronary Computed Tomography Angiography in 45- to 55-Year-Old Women With a History of Preeclampsia.
     Circulation. 2018;137:877-879.
     PubMed     Text format    
     
     
     
139. WEI J, Bakir M, Darounian N, Li Q, et al
     Myocardial Scar Is Prevalent and Associated With Subclinical Myocardial Dysfunction in Women With Suspected Ischemia But No Obstructive Coronary Artery Disease: From the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study.
     Circulation. 2018;137:874-876.
     PubMed     Text format    
     
     
     
140. MINISSIAN MB, Kilpatrick S, Eastwood JA, Robbins WA, et al
     Association of Spontaneous Preterm Delivery and Future Maternal Cardiovascular Disease.
     Circulation. 2018;137:865-871.
     PubMed     Text format     Abstract available
     
     
     
141. O'NEIL A, Scovelle AJ, Milner AJ, Kavanagh A, et al
     Gender/Sex as a Social Determinant of Cardiovascular Risk.
     Circulation. 2018;137:854-864.
     PubMed     Text format     Abstract available
     
     
     
142. GRAVES CR, Davis SF
     Cardiovascular Complications in Pregnancy: It Is Time for Action.
     Circulation. 2018 Feb 19. pii: CIRCULATIONAHA.117.031592.
     PubMed     Text format     Abstract available
     
     
     
143. SAVONITTO S, Ferri LA, Piatti L, Grosseto D, et al
     A Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients with Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization.
     Circulation. 2018 Feb 19. pii: CIRCULATIONAHA.117.032180.
     PubMed     Text format     Abstract available
     
     
     
144. TRIANT VA, Perez J, Regan S, Massaro JM, et al
     Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection.
     Circulation. 2018 Feb 14. pii: CIRCULATIONAHA.117.028975.
     PubMed     Text format     Abstract available
     
     
     
145. 
     Correction to: Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Pr
     Circulation. 2018;137:e29.
     PubMed     Text format    
     
     
     
146. HADLEY MB, Baumgartner J, Vedanthan R
     Developing a Clinical Approach to Air Pollution and Cardiovascular Health.
     Circulation. 2018;137:725-742.
     PubMed     Text format     Abstract available
     
     
     
147. KHERA A, Greenland P
     Coronary Artery Calcium: If Measuring Once Is Good, Is Twice Better?
     Circulation. 2018;137:680-683.
     PubMed     Text format    
     
     
     
148. GOTTESMAN RF
     Survivor's Remorse: Is There an Increased Risk of Dementia After Surviving a Myocardial Infarction?
     Circulation. 2018;137:578-580.
     PubMed     Text format    
     
     
     
149. CAO D, Schiattarella GG, Villalobos E, Jiang N, et al
     Cytosolic DNA Sensing Promotes Macrophage Transformation and Governs Myocardial Ischemic Injury.
     Circulation. 2018 Feb 1. pii: CIRCULATIONAHA.117.031046.
     PubMed     Text format     Abstract available
     
     
     
150. MEHTA LS, Watson KE, Barac A, Beckie TM, et al
     Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.
     Circulation. 2018 Feb 1. pii: CIR.0000000000000556.
     PubMed     Text format     Abstract available
     
     
     January 2018
151. MERGHANI A, Maestrini V, Rosmini S, Cox AT, et al
     Response by Merghani et al to Letters Regarding Article, "Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile".
     Circulation. 2018;137:541-542.
     PubMed     Text format    
     
     
     
152. SCHMERMUND A
     Letter by Schmermund Regarding Article, "Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile".
     Circulation. 2018;137:539-540.
     PubMed     Text format    
     
     
     
153. HARRELL TE, Stoebner RA, Boswell GE
     Letter by Harrell et al Regarding Article, "Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile".
     Circulation. 2018;137:537-538.
     PubMed     Text format    
     
     
     
154. JIN-SHAN H, Xue-Bin L
     Letter by Jin-shan and Xue-bin Regarding Article, "Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile".
     Circulation. 2018;137:536.
     PubMed     Text format    
     
     
     
155. RENA G, Lang CC
     Repurposing Metformin for Cardiovascular Disease.
     Circulation. 2018;137:422-424.
     PubMed     Text format    
     
     
     
156. SIMES J, Robledo KP, White HD, Espinoza D, et al
     D-dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events and Cancer in Stable Coronary Heart Disease Patients: The LIPID Study.
     Circulation. 2018 Jan 24. pii: CIRCULATIONAHA.117.029901.
     PubMed     Text format     Abstract available
     
     
     
157. HOFMANN R, James SK
     Routine Oxygen Supplementation in Acute Cardiovascular Disease: The End of a Paradigm?
     Circulation. 2018;137:320-322.
     PubMed     Text format    
     
     
     
158. RADFORD NB, DeFina LF, Leonard D, Barlow CE, et al
     Cardiorespiratory Fitness, Coronary Artery Calcium and Cardiovascular Disease Events in a Cohort of Generally Healthy, Middle Aged Men: Results from the Cooper Center Longitudinal Study.
     Circulation. 2018 Jan 17. pii: CIRCULATIONAHA.117.032708.
     PubMed     Text format     Abstract available
     
     
     
159. IANIRO G, Cammarota G, Gasbarrini A
     Letter by Ianiro et al Regarding Article, "Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium".
     Circulation. 2018;137:213-214.
     PubMed     Text format    
     
     
     
160. 
     Correction to: 2017 American Heart Association Focused Update on Adult Basic Life Support and Cardiopulmonary Resuscitation Quality: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular
     Circulation. 2018;137:e14.
     PubMed     Text format    
     
     
     December 2017
161. GIUGLIANO RP, Cannon CP, Blazing MA, Nicolau JC, et al
     Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With vs. Without Diabetes: Results from IMPROVE-IT.
     Circulation. 2017 Dec 20. pii: CIRCULATIONAHA.117.030950.
     PubMed     Text format     Abstract available
     
     
     
162. 
     Correction to: Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction.
     Circulation. 2017;136:e469.
     PubMed     Text format    
     
     
     
163. BENSON MD, Yang Q, Ngo D, Zhu Y, et al
     The Genetic Architecture of the Cardiovascular Risk Proteome.
     Circulation. 2017 Dec 19. pii: CIRCULATIONAHA.117.029536.
     PubMed     Text format     Abstract available
     
     
     
164. 
     Correction to: 2017 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary.
     Circulation. 2017;136:e468.
     PubMed     Text format    
     
     
     
165. PAZOKI R, Dehghan A, Evangelou E, Warren H, et al
     Genetic Predisposition to High Blood Pressure and Lifestyle Factors: Associations with Midlife Blood Pressure Levels and Cardiovascular Events.
     Circulation. 2017 Dec 18. pii: CIRCULATIONAHA.117.030898.
     PubMed     Text format     Abstract available
     
     
     
166. GOLDSTONE AB, Chiu P, Baiocchi M, Wang H, et al
     Second Arterial versus Venous Conduits for Multi-Vessel Coronary Artery Bypass Surgery in California.
     Circulation. 2017 Dec 14. pii: CIRCULATIONAHA.117.030959.
     PubMed     Text format     Abstract available
     
     
     
167. GAO L, Gregorich ZR, Zhu W, Mattapally S, et al
     Large Cardiac-Muscle Patches Engineered from Human Induced-Pluripotent Stem-Cell-Derived Cardiac Cells Improve Recovery from Myocardial Infarction in Swine.
     Circulation. 2017 Dec 12. pii: CIRCULATIONAHA.117.030785.
     PubMed     Text format     Abstract available
     
     
     
168. AHN JM, Park SJ
     Response by Ahn and Park to Letter Regarding Article, "Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease: Data From a Prospective IRIS-FFR Registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve)"
     Circulation. 2017;136:2393-2394.
     PubMed     Text format    
     
     
     
169. JIN-SHAN H, Xue-Bin L
     Letter by Jin-Shan and Xue-Bin Regarding Article, "Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease: Data From a Prospective IRIS-FFR Registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve)".
     Circulation. 2017;136:2392.
     PubMed     Text format    
     
     
     
170. HAN YL, Rutherford JD
     Recent Evolution of the Treatment of Coronary Artery Disease in China: A Conversation With Ya-Ling Han, MD, PhD.
     Circulation. 2017;136:2298-2302.
     PubMed     Text format    
     
     
     
171. FRANKENREITER S, Bednarczyk P, Kniess A, Bork NI, et al
     cGMP-Elevating Compounds and Ischemic Conditioning Provide Cardioprotection Against Ischemia and Reperfusion Injury via Cardiomyocyte-Specific BK Channels.
     Circulation. 2017;136:2337-2355.
     PubMed     Text format     Abstract available
     
     
     
172. ZHANG L, Wei TT, Li Y, Li J, et al
     Functional Metabolomics Characterizes a Key Role for N-Acetyl-Neuraminic Acid in Coronary Artery Diseases.
     Circulation. 2017 Dec 6. pii: CIRCULATIONAHA.117.031139.
     PubMed     Text format     Abstract available
     
     
     November 2017
173. JIN-SHAN H, Xue-Bin L
     Letter by Jin-shan and Xue-bin Regarding Article, "Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)".
     Circulation. 2017;136:2202-2203.
     PubMed     Text format    
     
     
     
174. YAN W, Guo Y, Tao L, Lau WB, et al
     C1q/Tumor Necrosis Factor-Related Protein-9 Regulates the Fate of Implanted Mesenchymal Stem Cells and Mobilizes Their Protective Effects Against Ischemic Heart Injury via Multiple Novel Signaling Pathways.
     Circulation. 2017;136:2162-2177.
     PubMed     Text format     Abstract available
     
     
     
175. KOSKINEN J, Juonala M, Dwyer T, Venn A, et al
     Impact of Lipid Measurements in Youth in Addition to Conventional Clinic-Based Risk Factors on Predicting Preclinical Atherosclerosis in Adulthood: The International Childhood Cardiovascular Cohort (i3C) Consortium.
     Circulation. 2017 Nov 23. pii: CIRCULATIONAHA.117.029726.
     PubMed     Text format     Abstract available
     
     
     
176. HORCKMANS M, Bianchini M, Santovito D, Megens RTA, et al
     Pericardial Adipose Tissue Regulates Granulopoiesis, Fibrosis and Cardiac Function After Myocardial Infarction.
     Circulation. 2017 Nov 22. pii: CIRCULATIONAHA.117.028833.
     PubMed     Text format     Abstract available
     
     
     
177. JENSEN MK, Aroner SA, Mukamal KJ, Furtado JD, et al
     HDL Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts.
     Circulation. 2017 Nov 21. pii: CIRCULATIONAHA.117.031276.
     PubMed     Text format     Abstract available
     
     
     
178. CICCARELLI G, Barbato E, Toth GG, Gahl B, et al
     Angiography versus Hemodynamics to Predict the Natural History of Coronary Stenoses: A FAME 2-Substudy.
     Circulation. 2017 Nov 21. pii: CIRCULATIONAHA.117.028782.
     PubMed     Text format     Abstract available
     
     
     
179. CHAPMAN AR, Shah ASV, Lee KK, Anand A, et al
     Long Term Outcomes in Patients with Type 2 Myocardial Infarction and Myocardial Injury.
     Circulation. 2017 Nov 17. pii: CIRCULATIONAHA.117.031806.
     PubMed     Text format     Abstract available
     
     
     
180. LEHMANN N, Erbel RA, Mahabadi AA, Rauwolf M, et al
     Value of Progression of Coronary Artery Calcification for Risk Prediction of Coronary and Cardiovascular Events: Result of the Heinz Nixdorf Recall (HNR) Study.
     Circulation. 2017 Nov 15. pii: CIRCULATIONAHA.116.027034.
     PubMed     Text format     Abstract available
     
     
     
181. JOLLIS JG, Al-Khalidi HR, Roettig ML, Berger PB, et al
     Impact of Regionalization of ST Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services Transported Patients Presenting to Hospitals with Percutaneous Coronary Intervention: Mission: Lifeline Accelerator-2.
     Circulation. 2017 Nov 14. pii: CIRCULATIONAHA.117.032446.
     PubMed     Text format     Abstract available
     
     
     
182. THAN MP, Pickering JW, Dryden JM, Lord SJ, et al
     ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical Pathway.
     Circulation. 2017 Nov 14. pii: CIRCULATIONAHA.117.031984.
     PubMed     Text format     Abstract available
     
     
     
183. PEREZ DE ISLA L, Saltijeral Cerezo A, Mata P
     Response by Perez de Isla et al to Letter Regarding Article, "Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)".
     Circulation. 2017;136:1984.
     PubMed     Text format    
     
     
     
184. NATALE F, Di Maio M, Calabro P
     Letter by Natale et al Regarding Article, "Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)".
     Circulation. 2017;136:1982-1983.
     PubMed     Text format    
     
     
     
185. KHERA R, Hong JC, Saxena A, Arrieta A, et al
     Burden of Catastrophic Health Expenditures for Acute Myocardial Infarction and Stroke Among Uninsured in the United States.
     Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.030128.
     PubMed     Text format     Abstract available
     
     
     
186. UDELL JA, Yuan Z, Rush T, Sicignano NM, et al
     Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Co-Transporter 2 Inhibitor: Results From the EASEL Population-Based Cohort Study.
     Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.031227.
     PubMed     Text format     Abstract available
     
     
     
187. BONACA MP, Nault P, Giugliano RP, Keech AC, et al
     Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
     Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.032235.
     PubMed     Text format     Abstract available
     
     
     
188. MAHAFFEY KW, Neal B, Perkovic V, de Zeeuw D, et al
     Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).
     Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.032038.
     PubMed     Text format     Abstract available
     
     
     
189. VERMA S, Mazer CD, Al-Omran M, Inzucchi SE, et al
     Cardiovascular Outcomes and Safety of Empagliflozin in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: A Subanalysis of EMPA-REG OUTCOME.
     Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.032031.
     PubMed     Text format     Abstract available
     
     
     
190. BURSTEIN B, Altobelli KK, Williams K, Cannon CP, et al
     Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.
     Circulation. 2017;136:1860-1862.
     PubMed     Text format    
     
     
     
191. DRAGER LF, McEvoy RD, Barbe F, Lorenzi-Filho G, et al
     Sleep Apnea and Cardiovascular Disease: Lessons From Recent Trials and Need for Team Science.
     Circulation. 2017;136:1840-1850.
     PubMed     Text format     Abstract available
     
     
     
192. LEE JM, Hwang D, Park J, Zhang J, et al
     Exploring Coronary Circulatory Response to Stenosis and Its Association With Invasive Physiologic Indexes Using Absolute Myocardial Blood Flow and Coronary Pressure.
     Circulation. 2017;136:1798-1808.
     PubMed     Text format     Abstract available
     
     
     
193. OLASVEENGEN TM, de Caen AR, Mancini ME, Maconochie IK, et al
     2017 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary.
     Circulation. 2017 Nov 6. pii: CIR.0000000000000541.
     PubMed     Text format     Abstract available
     
     
     
194. ATKINS DL, de Caen AR, Berger S, Samson RA, et al
     2017 American Heart Association Focused Update on Pediatric Basic Life Support and Cardiopulmonary Resuscitation Quality: An Update to the American Heart Association Guidelines for Cardio pulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2017 Nov 6. pii: CIR.0000000000000540.
     PubMed     Text format     Abstract available
     
     
     
195. KLEINMAN ME, Goldberger ZD, Rea T, Swor RA, et al
     2017 American Heart Association Focused Update on Adult Basic Life Support and Cardiopulmonary Resuscitation Quality: An Update to the American Heart Association Guidelines for Cardio pulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2017 Nov 6. pii: CIR.0000000000000539.
     PubMed     Text format     Abstract available
     
     
     
196. TWERENBOLD R, Badertscher P, Boeddinghaus J, Nestelberger T, et al
     0/1-Hour Triage Algorithm for Myocardial Infarction in Patients with Renal Dysfunction.
     Circulation. 2017 Nov 3. pii: CIRCULATIONAHA.117.028901.
     PubMed     Text format     Abstract available
     
     
     
197. FEARON WF, Nishi T, De Bruyne B, Boothroyd DB, et al
     Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Mul
     Circulation. 2017 Nov 2. pii: CIRCULATIONAHA.117.031907.
     PubMed     Text format     Abstract available
     
     
     October 2017
198. GAUDINO M, Antoniades C, Benedetto U, Deb S, et al
     Mechanisms, Consequences, and Prevention of Coronary Graft Failure.
     Circulation. 2017;136:1749-1764.
     PubMed     Text format     Abstract available
     
     
     
199. HENG EL, Gatzoulis MA, Uebing A, Sethia B, et al
     Immediate and Midterm Cardiac Remodeling After Surgical Pulmonary Valve Replacement in Adults With Repaired Tetralogy of Fallot: A Prospective Cardiovascular Magnetic Resonance and Clinical Study.
     Circulation. 2017;136:1703-1713.
     PubMed     Text format     Abstract available
     
     
     
200. IRIBARNE A, Schmoker JD, Malenka DJ, Leavitt BJ, et al
     Does Use of Bilateral Internal Mammary Artery Grafting Reduce Long-Term Risk of Repeat Coronary Revascularization? A Multicenter Analysis.
     Circulation. 2017;136:1676-1685.
     PubMed     Text format     Abstract available
     
     
     
201. RUEL M, Gardner TJ
     Introduction to the 2017 Cardiovascular Surgery-Themed Issue of Circulation.
     Circulation. 2017;136:1675.
     PubMed     Text format    
     
     
     
202. KRITTANAWONG C
     Future Physicians in the Era of Precision Cardiovascular Medicine.
     Circulation. 2017;136:1572-1574.
     PubMed     Text format    
     
     
     
203. LYTVYN Y, Bjornstad P, Udell JA, Lovshin JA, et al
     Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.
     Circulation. 2017;136:1643-1658.
     PubMed     Text format     Abstract available
     
     
     
204. CARNETHON MR, Pu J, Howard G, Albert MA, et al
     Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association.
     Circulation. 2017 Oct 23. pii: CIR.0000000000000534.
     PubMed     Text format     Abstract available
     
     
     
205. MCEVOY JW, Ibrahim K, Kickler TS, Clarke WA, et al
     Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial.
     Circulation. 2017 Oct 18. pii: CIRCULATIONAHA.117.031678.
     PubMed     Text format     Abstract available
     
     
     
206. VAN DIEPEN S, Katz JN, Albert NM, Henry TD, et al
     Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association.
     Circulation. 2017;136:e232-e268.
     PubMed     Text format     Abstract available
     
     
     
207. BORTOLOTTI F, Ruozi G, Falcione A, Doimo S, et al
     In Vivo Functional Selection Identifies Cardiotrophin-1 as a Cardiac Engraftment Factor for Mesenchymal Stromal Cells.
     Circulation. 2017;136:1509-1524.
     PubMed     Text format     Abstract available
     
     
     
208. MAGNUSSEN C, Niiranen TJ, Ojeda F, Gianfagna F, et al
     Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).
     Circulation. 2017 Oct 16. pii: CIRCULATIONAHA.117.028981.
     PubMed     Text format     Abstract available
     
     
     
209. MCCARROLL CS, He W, Foote K, Bradley A, et al
     Runx1 Deficiency Protects Against Adverse Cardiac Remodeling Following Myocardial Infarction.
     Circulation. 2017 Oct 13. pii: CIRCULATIONAHA.117.028911.
     PubMed     Text format     Abstract available
     
     
     
210. SUNA G, Wojakowski W, Lynch M, Barallobre-Barreiro J, et al
     Extracellular Matrix Proteomics Reveals Interplay of Aggrecan and Aggrecanases in Vascular Remodeling of Stented Coronary Arteries.
     Circulation. 2017 Oct 13. pii: CIRCULATIONAHA.116.023381.
     PubMed     Text format     Abstract available
     
     
     
211. SUNDBOLL J, Hovath-Puho E, Adelborg K, Schmidt M, et al
     Higher Risk of Vascular Dementia in Myocardial Infarction Survivors.
     Circulation. 2017 Oct 12. pii: CIRCULATIONAHA.117.029127.
     PubMed     Text format     Abstract available
     
     
     
212. HASEEB S, Alexander B, Baranchuk A
     Wine and Cardiovascular Health: A Comprehensive Review.
     Circulation. 2017;136:1434-1448.
     PubMed     Text format     Abstract available
     
     
     
213. LACRAZ GPA, Junker JP, Gladka MM, Molenaar B, et al
     Tomo-Seq Identifies SOX9 as a Key Regulator of Cardiac Fibrosis During Ischemic Injury.
     Circulation. 2017;136:1396-1409.
     PubMed     Text format     Abstract available
     
     
     
214. MILLER-HODGES EV, Anand A, Shah ASV, Chapman AR, et al
     High-Sensitivity Cardiac Troponin and the Risk Stratification of Patients with Renal Impairment Presenting with Suspected Acute Coronary Syndrome.
     Circulation. 2017 Oct 4. pii: CIRCULATIONAHA.117.030320.
     PubMed     Text format     Abstract available
     
     
     
215. SMOLDEREN KGE, Gosch KG, Buchanan DM, Spertus JA, et al
     Response by Smolderen et al to Letter Regarding Article, "Depression Treatment and 1-Year Mortality After Acute Myocardial Infarction: Insights From the TRIUMPH Registry (Translational Research Investigating Underlying Disparities in Acute Myocardial
     Circulation. 2017;136:1355-1356.
     PubMed     Text format    
     
     
     
216. MA LL, Kong FJ, Ge JB
     Letter by Ma et al Regarding Article, "Depression Treatment and 1-Year Mortality After Acute Myocardial Infarction: Insights From the TRIUMPH Registry (Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients
     Circulation. 2017;136:1353-1354.
     PubMed     Text format    
     
     
     
217. HEAD SJ, Milojevic M, Taggart DP, Puskas JD, et al
     Current Practice of State-of-the-Art Surgical Coronary Revascularization.
     Circulation. 2017;136:1331-1345.
     PubMed     Text format     Abstract available
     
     
     September 2017
218. BOHULA EA, Wiviott SD, Giugliano RP, Blazing MA, et al
     Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients with Acute Coronary Syndrome in IMPROVE-IT.
     Circulation. 2017 Sep 30. pii: CIRCULATIONAHA.117.029095.
     PubMed     Text format     Abstract available
     
     
     
219. BERRY C, McClure JD, Oldroyd KG
     Meta-Analysis of Death and Myocardial Infarction in the DEFINE-FLAIR and iFR-SWEDEHEART Trials.
     Circulation. 2017 Sep 28. pii: CIRCULATIONAHA.117.030430.
     PubMed     Text format     Abstract available
     
     
     
220. GOYAL A, Gluckman TJ, Tcheng JE
     What's in a Name? The New ICD-10 (10th Revision of the International Statistical Classification of Diseases and Related Health Problems) Codes and Type 2 Myocardial Infarction.
     Circulation. 2017;136:1180-1182.
     PubMed     Text format    
     
     
     
221. WILSON PWF, Gagnon D
     Diabetes Mellitus and Control of Cardiovascular Disease Risk Factors: A Challenge to Improve Usual Care.
     Circulation. 2017;136:1204-1206.
     PubMed     Text format    
     
     
     
222. SUNDSTROM J, Hedberg J, Thuresson M, Aarskog P, et al
     Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort Study.
     Circulation. 2017;136:1183-1192.
     PubMed     Text format     Abstract available
     
     
     
223. KAIER TE, Twerenbold R, Puelacher C, Marjot J, et al
     Direct Comparison of Cardiac Myosin-Binding Protein C with Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction.
     Circulation. 2017 Sep 26. pii: CIRCULATIONAHA.117.028084.
     PubMed     Text format     Abstract available
     
     
     
224. REBOLL MR, Korf-Klingebiel M, Klede S, Polten F, et al
     Endoplasmic Reticulum Membrane Protein Complex Subunit 10 (EMC10) is a Bone Marrow-Derived Angiogenic Growth Factor Promoting Tissue Repair After Myocardial Infarction.
     Circulation. 2017 Sep 20. pii: CIRCULATIONAHA.117.029980.
     PubMed     Text format     Abstract available
     
     
     
225. CREA F, Libby P
     Acute Coronary Syndromes: The Way Forward From Mechanisms to Precision Treatment.
     Circulation. 2017;136:1155-1166.
     PubMed     Text format     Abstract available
     
     
     
226. QUAIFE-RYAN GA, Sim CB, Ziemann M, Kaspi A, et al
     Multicellular Transcriptional Analysis of Mammalian Heart Regeneration.
     Circulation. 2017;136:1123-1139.
     PubMed     Text format     Abstract available
     
     
     
227. NALLAMOTHU BK, Hill JA
     Preprints and Cardiovascular Science: Prescient or Premature?
     Circulation. 2017 Sep 14. pii: CIRCULATIONAHA.117.031238.
     PubMed     Text format     Abstract available
     
     
     
228. WANNER C, Lachin JM, Inzucchi SE, Fitchett D, et al
     Empagliflozin and Clinical Outcomes in Patients with Type 2 Diabetes, Established Cardiovascular Disease and Chronic Kidney Disease.
     Circulation. 2017 Sep 13. pii: CIRCULATIONAHA.117.028268.
     PubMed     Text format     Abstract available
     
     
     
229. LINDAHL B, Baron T, Erlinge D, Hadziosmanovic N, et al
     Response by Lindahl et al to Letter Regarding Article, "Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease".
     Circulation. 2017;136:1082-1083.
     PubMed     Text format    
     
     
     
230. CILIBERTI G, Capucci A
     Letter by Ciliberti and Capucci Regarding Article, "Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease".
     Circulation. 2017;136:1080-1081.
     PubMed     Text format    
     
     
     
231. DEHARO P, Ducrocq G, Bode C, Cohen M, et al
     Timing of Angiography and Outcomes in High-Risk Patients with Non-ST Segment Elevation Myocardial Infarction Managed Invasively: Insights from the TAO Trial.
     Circulation. 2017 Sep 11. pii: CIRCULATIONAHA.117.029779.
     PubMed     Text format     Abstract available
     
     
     August 2017
232. WANG WE, Li L, Xia X, Fu W, et al
     Dedifferentiation, Proliferation, and Redifferentiation of Adult Mammalian Cardiomyocytes After Ischemic Injury.
     Circulation. 2017;136:834-848.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: